David D.L. Bowtell

Also affiliated with Peter MacCallum Cancer Centre

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 1%percentile

40.8Author DataRank

Indexed papers

9in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 9 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Comprehensive genomic characterization of squamous cell lung cancers

Nature(2012)10.1038/nature11404

Top 1%

11.0DataRank

Top 1%4036 citations

Gad Getz, Stephen E. Schumacher, Petar Stojanov, Chang‐Jiun Wu, Hailei Zhang +326 more

Papers

Driven by 52 papers — median percentile 95. Top paper: “Comprehensive genomic characterization of squamous cell lung cancers”.

Comprehensive genomic characterization of squamous cell lung cancers

Nature(2012)10.1038/nature11404

Top 1%

11.0DataRank

Top 1%4036 citations

Gad Getz, Stephen E. Schumacher, Petar Stojanov, Chang‐Jiun Wu, Hailei Zhang +326 more

An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics

Cell(2018)10.1016/j.cell.2018.02.052

Top 2%

8.1DataRank

Top 2%3980 citations

Katherine A. Hoadley, Laila M. Poisson, Alexander J. Lazar, Andrew D. Cherniack, Albert J. Kovatich +866 more

Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing

Nature Genetics(2020)10.1038/s41588-019-0576-7

N/A

8.1DataRank · unranked

783 citations

Jake June-Koo Lee, Ruibin Xi, Dhawal Jain, Youngsook L. Jung, Lixing Yang +89 more

Characterizing genetic intra-tumor heterogeneity across 2,658 human cancer genomes

Cell(2021)10.1016/j.cell.2021.03.009

N/A

7.3DataRank · unranked

560 citations

Ignaty Leshchiner, Kerstin Haase, Maxime Tarabichi, Jeff Wintersinger, Amit G. Deshwar +64 more

Pan-cancer analysis of whole genomes identifies driver rearrangements promoted by LINE-1 retrotransposition

Nature Genetics(2020)10.1038/s41588-019-0562-0

N/A

7.0DataRank · unranked

483 citations

Eva G. Alvarez, Adrian Baez‐Ortega, Jorge Zamora, Fran Supek, Jonas Demeulemeester +80 more

Perspective on Oncogenic Processes at the End of the Beginning of Cancer Genomics

Cell(2018)10.1016/j.cell.2018.03.033

Top 3%

6.4DataRank

Top 3%447 citations

Matthew H. Bailey, Hoifung Poon, Vesteinn Thorsson, Antonio Colaprico, Andreas Bender +883 more

Pan-cancer analysis of whole genomes

Nature(2020)10.1038/s41586-020-1969-6

Top 3%

5.9DataRank

Top 3%3307 citations

Lauri A. Aaltonen, Federico Abascal, Adam Abeshouse, Hiroyuki Aburatani, David J. Adams +1244 more

Machine Learning Detects Pan-cancer Ras Pathway Activation in The Cancer Genome Atlas

Cell Reports(2018)10.1016/j.celrep.2018.03.046

N/A

5.5DataRank · unranked

186 citations

Francisco Sanchez-Vega, Konnor C. La, Joshua Armenia, Walid K. Chatila, Augustin Luna +869 more

Analyses of non-coding somatic drivers in 2,658 cancer whole genomes

Nature(2020)10.1038/s41586-020-1965-x

Top 5%

4.6DataRank

Top 5%668 citations

Federico Abascal, Jeremiah A. Wala, Ofer Shapira, Grace Tiao, Henrik Hornshøj +1240 more

Acquired RAD51C Promoter Methylation Loss Causes PARP Inhibitor Resistance in High-Grade Serous Ovarian Carcinoma

Cancer Research(2021)10.1158/0008-5472.can-21-0774

N/A

2.1DataRank · unranked

90 citations

Olga Kondrashova, Rachel M. Hurley, Cordelia D. McGehee, Cassandra J. Vandenberg, Gwo‐Yaw Ho +25 more

Clinical and pathological associations of PTEN expression in ovarian cancer: a multicentre study from the Ovarian Tumour Tissue Analysis Consortium

British Journal of Cancer(2020)10.1038/s41416-020-0900-0

Top 10%

2.1DataRank

Top 10%68 citations

Dominique‐Laurent Couturier, Anna Paterson, Anthony N. Karnezis, Christine Chow, Tayyebeh M. Nazeran +92 more

Development and Validation of the Gene Expression Predictor of High-grade Serous Ovarian Carcinoma Molecular SubTYPE (PrOTYPE)

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-0103

N/A

1.8DataRank · unranked

76 citations

Joshy George, Chen Wang, Timothy Budden, Tuan Zea Tan, Derek S. Chiu +134 more

High-coverage whole-genome analysis of 1220 cancers reveals hundreds of genes deregulated by rearrangement-mediated cis-regulatory alterations

Nature Communications(2020)10.1038/s41467-019-13885-w

Top 13%

1.6DataRank

Top 13%76 citations

Fengju Chen, Nuno A. Fonseca, Yao He, Masashi Fujita, Hidewaki Nakagawa +91 more

Integrated genomic analyses of ovarian carcinoma

Nature(2011)10.1038/nature10166

N/A

1.3DataRank · unranked

8094 citations

Debra Bell, Andrew Berchuck, Michael J. Birrer, Jeremy Chien, D. W. Cramer +268 more

Refined cut-off for TP53 immunohistochemistry improves prediction of TP53 mutation status in ovarian mucinous tumors: implications for outcome analyses

Modern Pathology(2020)10.1038/s41379-020-0618-9

N/A

1.3DataRank · unranked

43 citations

Dane Cheasley, Cécile Le Page, Matthew J. Wakefield, Michelle da Cunha Torres, Simone M. Rowley +93 more

Oncogenic Signaling Pathways in The Cancer Genome Atlas

Cell(2018)10.1016/j.cell.2018.03.035

N/A

1.2DataRank · unranked

3322 citations

Marco Mina, Joshua Armenia, Walid K. Chatila, Augustin Luna, Konnor C. La +891 more

ARID1A Mutations in Endometriosis-Associated Ovarian Carcinomas

New England Journal of Medicine(2010)10.1056/nejmoa1008433

N/A

1.1DataRank · unranked

1683 citations

Sohrab P. Shah, Osama M. Al-Agha, Yongjun Zhao, Kane Tse, Thomas Zeng +49 more

The evolutionary history of 2,658 cancers

Nature(2020)10.1038/s41586-019-1907-7

N/A

1.1DataRank · unranked

1106 citations

Clemency Jolly, Ignaty Leshchiner, Stefan C. Dentro, Santiago Gonzalez, Daniel Rosebrock +59 more

Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary

The Journal of Pathology(2010)10.1002/path.2696

N/A

1.0DataRank · unranked

826 citations

Dariush Etemadmoghadam, Jillian Temple, Andy G. Lynch, Mohamed Riad, Raghwa Sharma +10 more

Profiling the immune landscape in mucinous ovarian carcinoma

Gynecologic Oncology(2022)10.1016/j.ygyno.2022.10.022

N/A

0.993DataRank · unranked

26 citations

Phineas T. Hamilton, Katy Milne, Shelby Thornton, Bronwyn Harris, Ashley Weir +40 more

Integrated Genome-Wide DNA Copy Number and Expression Analysis Identifies Distinct Mechanisms of Primary Chemoresistance in Ovarian Carcinomas

Clinical Cancer Research(2009)10.1158/1078-0432.ccr-08-1564

N/A

0.858DataRank · unranked

303 citations

Anna deFazio, Rameen Beroukhim, Joshy George, Gad Getz, Richard Tothill +26 more

Ovarian and Breast Cancer Risks Associated With Pathogenic Variants in RAD51C and RAD51D

JNCI Journal of the National Cancer Institute(2020)10.1093/jnci/djaa030

N/A

0.769DataRank · unranked

168 citations

Honglin Song, Goska Leslie, Christoph Engel, Eric Hahnen, Bernd Auber +56 more

p53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium study

The Journal of Pathology Clinical Research(2023)10.1002/cjp2.311

Top 27%

0.751DataRank

Top 27%28 citations

Eunyoung Kang, Ashley Weir, Peter Rambau, Cheng‐Han Lee, Gregg Nelson +95 more

Prognostic gene expression signature for high-grade serous ovarian cancer

Annals of Oncology(2020)10.1016/j.annonc.2020.05.019

N/A

0.718DataRank · unranked

119 citations

S. Chen, Blake Gilks, C. Wang, S.C.Y. Leung, V. Chow +387 more

Therapeutic options for mucinous ovarian carcinoma

Gynecologic Oncology(2020)10.1016/j.ygyno.2019.12.015

N/A

0.685DataRank · unranked

95 citations

Dane Cheasley, Matthew J. Wakefield, Georgina L. Ryland, Prue E. Allan, Kathryn Alsop +35 more

The Prognostic Effect of Immune Cell Infiltration Depends on Molecular Subtype in Endometrioid Ovarian Carcinomas

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-22-3815

N/A

0.660DataRank · unranked

10 citations

Evan S. Cairns, Shelby Thornton, Bronwyn Harris, Katy Milne, Marcel Grube +23 more

Immunological and molecular features of the tumor microenvironment of long-term survivors of ovarian cancer

Journal of Clinical Investigation(2024)10.1172/jci179501

N/A

0.620DataRank · unranked

19 citations

Phineas T. Hamilton, Minh Tung Phung, Katy Milne, Bronwyn Harris, Shelby Thornton +73 more

Menopausal hormone therapy prior to the diagnosis of ovarian cancer is associated with improved survival

Gynecologic Oncology(2020)10.1016/j.ygyno.2020.06.481

N/A

0.510DataRank · unranked

29 citations

Siri Peterson, Alice W. Lee, Bhramar Mukherjee, Kelly M. Bakulski, Aliya Alimujiang +46 more

Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-22-1206

N/A

0.464DataRank · unranked

21 citations

Kylie L. Gorringe, Matthew J. Wakefield, Adelyn Bolithon, Chi Nam Ignatius Pang, Derek S. Chiu +95 more

Concurrent RB1 Loss and BRCA Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-23-3552

N/A

0.453DataRank · unranked

14 citations

Kazuaki Takahashi, Timothy Budden, Ahwan Pandey, Dinuka Ariyaratne, Tibor A. Zwimpfer +93 more

Ovarian cancer pathology characteristics as predictors of variant pathogenicity in BRCA1 and BRCA2

British Journal of Cancer(2023)10.1038/s41416-023-02263-5

N/A

0.449DataRank · unranked

19 citations

Susan J. Ramus, Melissa C. Southey, Nicola S. Meagher, Andreas Hadjisavvas, Esther M. John +87 more

Research autopsy programmes in oncology: shared experience from 14 centres across the world

The Journal of Pathology(2024)10.1002/path.6271

N/A

0.425DataRank · unranked

16 citations

Marion Maetens, Jody E. Hooper, Steffi Oesterreich, Adrian V. Lee, Lori Miller +41 more

Crowd-sourced benchmarking of single-sample tumor subclonal reconstruction

Nature Biotechnology(2024)10.1038/s41587-024-02250-y

Top 46%

0.396DataRank

Top 46%13 citations

Maxime Tarabichi, Alex Buchanan, Shadrielle M. G. Espiritu, Hongjiu Zhang, Kaiyi Zhu +83 more

Joint IARC/NCI International Cancer Seminar Series Report: expert consensus on future directions for ovarian carcinoma research

Carcinogenesis(2021)10.1093/carcin/bgab043

N/A

0.385DataRank · unranked

12 citations

Glauco Baiocchi, David D.L. Bowtell, Citadel J. Cabasag, Kathleen R. Cho, Renée T. Fortner +15 more

BRCA1 secondary splice-site mutations drive exon-skipping and PARP inhibitor resistance

medRxiv(2023)10.1101/2023.03.20.23287465

N/A

0.345DataRank · unranked

9 citations

John J. Krais, Cassandra J. Vandenberg, Yifan Wang, Pooja Patel, Kathy Q. Cai +30 more

Increased FOXJ1 protein expression is associated with improved overall survival in high-grade serous ovarian carcinoma: an Ovarian Tumor Tissue Analysis Consortium Study

British Journal of Cancer(2022)10.1038/s41416-022-02014-y

N/A

0.312DataRank · unranked

7 citations

Eunyoung Kang, Nicola S. Meagher, Gregg Nelson, Prafull Ghatage, Cheng‐Han Lee +88 more

High Prediagnosis Inflammation-Related Risk Score Associated with Decreased Ovarian Cancer Survival

Cancer Epidemiology Biomarkers & Prevention(2021)10.1158/1055-9965.epi-21-0977

N/A

0.312DataRank · unranked

7 citations

Minh Tung Phung, Bhramar Mukherjee, Kelly M. Bakulski, Hoda Anton-Culver, Elisa V. Bandera +43 more

Concurrent RB1 loss and BRCA -deficiency predicts enhanced immunological response and long-term survival in tubo-ovarian high-grade serous carcinoma

medRxiv(2023)10.1101/2023.11.09.23298321

N/A

0.269DataRank · unranked

5 citations

Kazuaki Takahashi, Timothy Budden, Ahwan Pandey, Dinuka Ariyaratne, Tibor A. Zwimpfer +94 more

Lifestyle and personal factors associated with having macroscopic residual disease after ovarian cancer primary cytoreductive surgery

Gynecologic Oncology(2022)10.1016/j.ygyno.2022.10.018

N/A

0.165DataRank · unranked

2 citations

Penelope M. Webb, Anna deFazio, Sián Fereday, Alice W. Lee, David D.L. Bowtell +25 more

Acquired RAD51C promoter methylation loss causes PARP inhibitor resistance in high grade serous ovarian carcinoma

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.12.10.419176

N/A

0.165DataRank · unranked

2 citations

Olga Kondrashova, Rachel M. Hurley, Cordelia D. McGehee, Cassandra J. Vandenberg, Gwo‐Yaw Ho +26 more

Author Correction: Cancer LncRNA Census reveals evidence for deep functional conservation of long noncoding RNAs in tumorigenesis

Communications Biology(2022)10.1038/s42003-022-03769-z

N/A

0.165DataRank · unranked

2 citations

Lars Feuerbach, Chen Hong, David Mas-Ponte, Randi Istrup Pedersen, PCAWG Drivers and Functional Interpretation Group +1255 more

Exome sequencing identifies HELB as a novel susceptibility gene for non-mucinous, non-high-grade-serous epithelial ovarian cancer

European Journal of Human Genetics(2025)10.1038/s41431-025-01786-0

N/A

0.109DataRank · unranked

1 citations

Jonathan P. Tyrer, Suzana Ezquina, Michelle R. Jones, John Baierl, Pei-Chen Peng +25 more

Methylation Signature Implicated in Immuno-Suppressive Activities in Tubo-Ovarian High-Grade Serous Carcinoma

Cancer Epidemiology Biomarkers & Prevention(2023)10.1158/1055-9965.epi-22-0941

N/A

0.104DataRank · unranked

1 citations

Matthew S. Block, Julie M. Cunningham, Mark E. Sherman, Bryan M. McCauley, Sebastian M. Armasu +20 more

Processed pseudogenes acquired somatically during cancer development

UNC Libraries(2020)10.17615/22vs-n122

N/A

0DataRank · unranked

0 citations

Vitor H. Teixeira, Iñigo Martincorena, Christine A. Iacobuzio–Donahue, John Marshall, Lucy Yates +27 more

Author Correction: Combined burden and functional impact tests for cancer driver discovery using DriverPower

Nature Communications(2022)10.1038/s41467-022-32343-8

N/A

0DataRank · unranked

0 citations

PCAWG Drivers and Functional Interpretation Working Group, Federico Abascal, Samirkumar B. Amin, Pratiti Bandopadhayay, Rameen Beroukhim +1242 more

Mathematical modeling of the evolution of resistance and aggressiveness of high-grade serous ovarian cancer from patient CA-125 time series

PLoS Computational Biology(2024)10.1371/journal.pcbi.1012073

N/A

0DataRank · unranked

5 citations

Jason I. Griffiths, Sián Fereday, Anna deFazio, David D.L. Bowtell, for Australian Ovarian Cancer Study +2 more

Exome sequencing identifies HELB as a novel susceptibility gene for non-mucinous, non-high-grade-serous epithelial ovarian cancer

medRxiv(2024)10.1101/2024.04.02.24304968

N/A

0DataRank · unranked

0 citations

Jonthan P. Tyrer, Suzana Ezquina, Michelle R. Jones, John Baierl, Pei-Chen Peng +16 more

752P Clinical and molecular predictors of outcome in patients with tubo-ovarian high-grade serous carcinoma and exceptional survival

Annals of Oncology(2024)10.1016/j.annonc.2024.08.813

N/A

0DataRank · unranked

0 citations

Ahwan Pandey, Sián Fereday, R.J.B-N. Coelho, L.T. Twomey, Dinuka Ariyaratne +15 more

Ovarian cancer risk and survival according to tumor sex hormone receptor expression: An ovarian Cancer association consortium and ovarian tumor tissue analysis consortium pooled analysis

Gynecologic Oncology(2025)10.1016/j.ygyno.2025.05.013

N/A

0DataRank · unranked

2 citations

Lauren Borho, Sarah E. Taylor, Linda E Kelemen, Anna deFazio, Penelope M. Webb +64 more

Data from Acquired RAD51C Promoter Methylation Loss Causes PARP Inhibitor Resistance in High-Grade Serous Ovarian Carcinoma

(2023)10.1158/0008-5472.c.6513498.v1

N/A

0DataRank · unranked

0 citations

Olga Kondrashova, Rachel M. Hurley, Cordelia D. McGehee, Cassandra J. Vandenberg, Gwo‐Yaw Ho +25 more

Patterns of Associations with Epidemiologic Factors by High-Grade Serous Ovarian Cancer Gene Expression Subtypes

Cancer Epidemiology Biomarkers & Prevention(2025)10.1158/1055-9965.epi-24-1143

N/A

0DataRank · unranked

0 citations

Kara L. Cushing‐Haugen, Kathryn L. Terry, Ellen L. Goode, Anna H. Wu, Holly R. Harris +23 more

UGDH promotes tumor-initiating cells and a fibroinflammatory tumor microenvironment in ovarian cancer

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.10.07.509566

N/A

0DataRank · unranked

2 citations

Rahul Kamdar, Franklin Ning, Soumya Korrapati, Michael W. Caminear, Lídia Hernandez +18 more

David D.L. Bowtell

Indexed papers

Top data-sharing exemplar

Papers